Intelligent Bio Solutions (INBS) EBIT (2020 - 2024)
Historic EBIT for Intelligent Bio Solutions (INBS) over the last 5 years, with Q1 2024 value amounting to -$3.0 million.
- Intelligent Bio Solutions' EBIT rose 5485.93% to -$3.0 million in Q1 2024 from the same period last year, while for Mar 2024 it was -$10.2 million, marking a year-over-year increase of 1595.45%. This contributed to the annual value of -$12.6 million for FY2023, which is 5107.86% down from last year.
- Per Intelligent Bio Solutions' latest filing, its EBIT stood at -$3.0 million for Q1 2024, which was up 5485.93% from -$2.0 million recorded in Q4 2023.
- Over the past 5 years, Intelligent Bio Solutions' EBIT peaked at -$662995.0 during Q3 2020, and registered a low of -$6.5 million during Q1 2023.
- Moreover, its 5-year median value for EBIT was -$2.1 million (2022), whereas its average is -$2.4 million.
- As far as peak fluctuations go, Intelligent Bio Solutions' EBIT soared by 5724.18% in 2022, and later tumbled by 38728.46% in 2023.
- Intelligent Bio Solutions' EBIT (Quarter) stood at -$662995.0 in 2020, then plummeted by 117.09% to -$1.4 million in 2021, then crashed by 48.05% to -$2.1 million in 2022, then grew by 6.55% to -$2.0 million in 2023, then crashed by 48.33% to -$3.0 million in 2024.
- Its EBIT stands at -$3.0 million for Q1 2024, versus -$2.0 million for Q4 2023 and -$2.5 million for Q3 2023.